Key result
Phage-based FMDV vaccines demonstrated a significant protective effect against FMDV compared to control (P<0.01), with no significant difference compared to the FMDV group (P>0.05).
Why the study?
Foot-and-mouth disease is a pathological disease affecting cloven-hoofed animals, prompting an assessment of the effect of bacteriophages in FMDV vaccine development.
Meta-Analysis (n=4)
p-value: p=<0.01
Phage-based FMDV vaccines show potential for preventing foot-and-mouth disease by inducing strong immune responses in animal models.
May advance phage-based FMDV vaccines in livestock; extends animal evidence but leaves translation open.
Foot-and-mouth disease (FMD) is a pathological disease caused by the foot- and-mouth disease virus (FMDV), which mainly affects cloven-hoofed animals. This study was conducted to a meta-analysis and experiment on the effect of bacteriophages used in the development of FMDV vaccines. A systematic search was conducted for the collection of the protection effect for the phage-based FMDV vaccine using sensitive search strategies. The extracted data were analyzed using Rev-Man 5.4 software. This experiment used the T7 phage to express the capsid protein VP1 of the OHM-02 strain, and the recombinant VP1 phage was termed OHM-T7. Antibodies and cytokines levels were assessed after immunizing BALB/C mice with OHM-T7. The results showed that a total of 115 articles were retrieved, and 4 of them met the inclusion criteria. There was no heterogeneity with I 2 = 0%, 20% or 43%. We used a fixed-effect model for meta-analysis, and the results showed a protective effect on FMDV between the phage group and control group ( P <0.01) and between FMDV group and control group ( P <0.01). Furthermore, when the phage group was compared to the FMDV group, there was also no significant difference ( P >0.05). After successfully obtained the ohm-t7 strain and immunized the mice, it could induce high levels of IFN-γ levels in mice with little effect on IL-4 levels. OHM-T7 could be used to detect antibodies produced by mice immunized with different FMDV antigens and produce high levels of anti-FMD antibodies. In summary, these results showed the potential of phage-based FMDV vaccines in FMDV prevention.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2020) conducted a meta-analysis in Foot-and-mouth disease (FMD) (n=4). Phage-based FMDV vaccine vs. Control group was evaluated on Protective effect on FMDV (p=<0.01). Phage-based FMDV vaccines demonstrated a significant protective effect against FMDV compared to control (P<0.01), with no significant difference compared to the FMDV group (P>0.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: